Spruce Biosciences Inc
OTC:SPRB

Watchlist Manager
Spruce Biosciences Inc Logo
Spruce Biosciences Inc
OTC:SPRB
Watchlist
Price: 78.74 USD 2.57% Market Closed
Market Cap: 75.1m USD

Wall Street
Price Targets

SPRB Price Targets Summary
Spruce Biosciences Inc

Wall Street analysts forecast SPRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

Lowest
Price Target
161.6 USD
105% Upside
Average
Price Target
213.69 USD
171% Upside
Highest
Price Target
271.95 USD
245% Upside
Spruce Biosciences Inc Competitors:
Price Targets
VYGR
Voyager Therapeutics Inc
276% Upside
206650
EuBiologics Co Ltd
65% Upside
2171
CARsgen Therapeutics Holdings Ltd
53% Upside
CRNX
Crinetics Pharmaceuticals Inc
68% Upside
ENTA
Enanta Pharmaceuticals Inc
18% Upside
RARE
Ultragenyx Pharmaceutical Inc
142% Upside
SERA
Sera Prognostics Inc
42% Upside
4974
Takara Bio Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Spruce Biosciences Inc

The compound annual growth rate of Spruce Biosciences Inc's revenue for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Spruce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Spruce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRB's stock price target?
Price Target
213.69 USD

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

What is Spruce Biosciences Inc's Revenue forecast?
Projected CAGR
28%

The compound annual growth rate of Spruce Biosciences Inc's revenue for the next 3 years is 28%.

Back to Top